Search results

Skip to results

Area of interest

Area of interestCOVID-19 (3)

Type

TypeGuidance (78)Indicators (9)News (10)NICE advice (10)Quality standards (23)Research recommendations (40)

Status

StatusAwaiting development (3)Discontinued (3)In development (4)Published (99)

Last updated

Last updatedLast 3 months (10)Last 6 months (20)Last year (37)Last 3 years (64)

Guidance programme

Guidance programmeClinical guidelines (32)COVID-19 rapid guidelines (2)Health technology evaluations (1)HealthTech guidance (11)Highly specialised technologies guidance (2)Medical technologies guidance (1)NICE guidelines (50)Public health guidelines (5)Safe staffing guidelines (1)Social care guidelines (20)Technology appraisal guidance (13)

Advice programme

Advice programmeEvidence summaries (4)Medtech innovation briefings (6)

Showing 201 to 201 of 201 results for dementia

Sort by

Semaglutide for treating mild cognitive impairment or mild dementia caused by Alzheimer's disease [ID6635]
Awaiting development Reference number: GID-TA11847 Expected publication date: TBC
Result type
Technology appraisal guidance
Status
Awaiting development

Previous page
1
3
4
Current page 5
Page 5 of 5

Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS) Clinical Knowledge Summaries
British National Formulary (BNF) British National Formulary
BNF for Children (BNFC) British National Formulary for Children
Life sciences
Library and knowledge services

What NICE does
Implementing NICE guidance
Get involved
About us
Careers
News, blogs and podcasts
Newsletters and alerts
Contact us
Leave feedback
Reusing our content
NICE UK Open Content Licence
Syndicate our content
Events

Facebook
X
YouTube
LinkedIn

Accessibility
Freedom of information
Glossary
Terms and conditions
Privacy notice
Cookies